Leptin Signaling Axis Specifically Associates with Clinical Prognosis and is Multifunctional in Regulating Cancer Progression

Overview

Journal Oncotarget

Specialty Oncology

Date 2018 Apr 24

PMID 29682217

Citations 18

Authors

Tsung-Chieh Lin

Kuan-Wei Huang

Chia-Wei Liu

Yu-Chan Chang

Wei-Ming Lin

Tse-Yen Yang

Michael Hsiao

Affiliations

Soon will be listed here.

Abstract

Leptin is a peptide hormone that has been characterized as the ligand of leptin receptor (). The observation of leptin secretion and leptin receptor expression beyond the normal tissues suggests the potentially critical roles other than its physiological function. In addition to the original function in controlling appetite and energy expenditure, leptin-mediated signaling axis through leptin receptor is multifunctional which plays role in the regulation toward broad types of cancer. Emerging evidences has indicated leptin's function in promoting several processes which are relevant to cancer progression including cell proliferation, metastasis, angiogenesis and drug resistance. We relatively display leptin and leptin receptor expression levels in pan-cancer panel based on the transcriptome analysis via dataset The Cancer Genome Atlas (TCGA), and show the clinical association of the axis in predicting cancer prognosis. The results indicate the pathological impacts of this axis on many types of cancer. This review mainly focuses on leptin-mediated effects and its downstream signaling related to the progression of cancers, and displays the clinical significance of this axis including the impact on cancer patient survival.

Citing Articles

Association of High Serum Leptin Level with Papillary Thyroid Carcinoma: A Case-Control Study.

Refahi R, Heidari Z, Mashhadi M Int J Hematol Oncol Stem Cell Res. 2023; 17(3):210-219.

PMID: 37817973 PMC: 10560642. DOI: 10.18502/ijhoscr.v17i3.13311.

Obesity and renal cell carcinoma: Biological mechanisms and perspectives.

Venkatesh N, Martini A, McQuade J, Msaouel P, Hahn A Semin Cancer Biol. 2023; 94:21-33.

PMID: 37286114 PMC: 10526958. DOI: 10.1016/j.semcancer.2023.06.001.

The effect of obesity on adipose-derived stromal cells and adipose tissue and their impact on cancer.

Bunnell B, Martin E, Matossian M, Brock C, Nguyen K, Collins-Burow B Cancer Metastasis Rev. 2022; 41(3):549-573.

PMID: 35999486 DOI: 10.1007/s10555-022-10063-1.

Obesity and Thyroid Cancer Risk: An Update.

Franchini F, Palatucci G, Colao A, Ungaro P, Macchia P, Nettore I Int J Environ Res Public Health. 2022; 19(3).

PMID: 35162142 PMC: 8834607. DOI: 10.3390/ijerph19031116.

A Role for Adipocytes and Adipose Stem Cells in the Breast Tumor Microenvironment and Regenerative Medicine.

Brock C, Hebert K, Artiles M, Wright M, Cheng T, Windsor G Front Physiol. 2021; 12:751239.

PMID: 34912237 PMC: 8667576. DOI: 10.3389/fphys.2021.751239.

References

Wang J, Liu R, Hawkins M, Barzilai N, Rossetti L . A nutrient-sensing pathway regulates leptin gene expression in muscle and fat. Nature. 1998; 393(6686):684-8. DOI: 10.1038/31474. View

Nadal-Serrano M, Sastre-Serra J, Valle A, Roca P, Oliver J . Chronic-leptin attenuates Cisplatin cytotoxicity in MCF-7 breast cancer cell line. Cell Physiol Biochem. 2015; 36(1):221-32. DOI: 10.1159/000374066. View

Han G, Li Y, Cao Y, Yue Z, Zhang Y, Wang L . Overexpression of leptin receptor in human glioblastoma: Correlation with vasculogenic mimicry and poor prognosis. Oncotarget. 2017; 8(35):58163-58171. PMC: 5601641. DOI: 10.18632/oncotarget.17344. View

Halaas J, Gajiwala K, Maffei M, Cohen S, Chait B, Rabinowitz D . Weight-reducing effects of the plasma protein encoded by the obese gene. Science. 1995; 269(5223):543-6. DOI: 10.1126/science.7624777. View

Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman J . Positional cloning of the mouse obese gene and its human homologue. Nature. 1994; 372(6505):425-32. DOI: 10.1038/372425a0. View

Strong A, Ohlstein J, Biagas B, Rhodes L, Pei D, Tucker H . Leptin produced by obese adipose stromal/stem cells enhances proliferation and metastasis of estrogen receptor positive breast cancers. Breast Cancer Res. 2015; 17:112. PMC: 4541745. DOI: 10.1186/s13058-015-0622-z. View

Senaris R, Garcia-Caballero T, Casabiell X, Gallego R, Castro R, Considine R . Synthesis of leptin in human placenta. Endocrinology. 1997; 138(10):4501-4. DOI: 10.1210/endo.138.10.5573. View

Kim Y, Kim S, Lee J, Seo J, Kim Y, Koh S . Effects of the expression of leptin and leptin receptor (OBR) on the prognosis of early-stage breast cancers. Cancer Res Treat. 2009; 38(3):126-32. PMC: 2741678. DOI: 10.4143/crt.2006.38.3.126. View

Chen C, Chang Y, Lan M, Breslin M . Leptin stimulates ovarian cancer cell growth and inhibits apoptosis by increasing cyclin D1 and Mcl-1 expression via the activation of the MEK/ERK1/2 and PI3K/Akt signaling pathways. Int J Oncol. 2013; 42(3):1113-9. DOI: 10.3892/ijo.2013.1789. View

10.

Gyorffy B, Schafer R . Meta-analysis of gene expression profiles related to relapse-free survival in 1,079 breast cancer patients. Breast Cancer Res Treat. 2008; 118(3):433-41. DOI: 10.1007/s10549-008-0242-8. View

11.

Fan Y, Gan Y, Shen Y, Cai X, Song Y, Zhao F . Leptin signaling enhances cell invasion and promotes the metastasis of human pancreatic cancer via increasing MMP-13 production. Oncotarget. 2015; 6(18):16120-34. PMC: 4599260. DOI: 10.18632/oncotarget.3878. View

12.

Mendoza-Perez J, Gu J, Herrera L, Tannir N, Zhang S, Matin S . Prognostic significance of promoter CpG island methylation of obesity-related genes in patients with nonmetastatic renal cell carcinoma. Cancer. 2017; 123(18):3617-3627. PMC: 5589484. DOI: 10.1002/cncr.30707. View

13.

Lin T, Lee T, Hsu S, Yang C . The molecular mechanism of leptin secretion and expression induced by aristolochic acid in kidney fibroblast. PLoS One. 2011; 6(2):e16654. PMC: 3033396. DOI: 10.1371/journal.pone.0016654. View

14.

Wu X, Yan Q, Zhang Z, Du G, Wan X . Acrp30 inhibits leptin-induced metastasis by downregulating the JAK/STAT3 pathway via AMPK activation in aggressive SPEC-2 endometrial cancer cells. Oncol Rep. 2012; 27(5):1488-96. DOI: 10.3892/or.2012.1670. View

15.

Zhu J, Sanborn J, Benz S, Szeto C, Hsu F, Kuhn R . The UCSC Cancer Genomics Browser. Nat Methods. 2009; 6(4):239-40. PMC: 5027375. DOI: 10.1038/nmeth0409-239. View

16.

Karabulut S, Afsar C, Karabulut M, Alis H, Erturk K, Karaman S . Serum leptin levels may have diagnostic and predictive roles in patients with pancreatic adenocarcinoma treated with gemcitabine-based chemotherapy. J BUON. 2016; 21(4):895-902. View

17.

Lee Y, Wu W, Lin H, Li W, Huang C, Hsu W . Prognostic Value of Leptin Receptor Overexpression in Upper Tract Urothelial Carcinomas in Taiwan. Clin Genitourin Cancer. 2017; 15(4):e653-e659. DOI: 10.1016/j.clgc.2017.01.002. View

18.

Feng H, Guo P, Wang J, Liu Q, Xu J, Yang H . [Association of the expression of leptin and leptin receptor with bone metastasis in pulmonary adenocarcinoma]. Zhonghua Zhong Liu Za Zhi. 2016; 38(11):840-844. DOI: 10.3760/cma.j.issn.0253-3766.2016.11.008. View

19.

Meerson A, Yehuda H . Leptin and insulin up-regulate miR-4443 to suppress NCOA1 and TRAF4, and decrease the invasiveness of human colon cancer cells. BMC Cancer. 2016; 16(1):882. PMC: 5109693. DOI: 10.1186/s12885-016-2938-1. View

20.

Hoffmann M, Fiedor E, Ptak A . 17β-Estradiol Reverses Leptin-Inducing Ovarian Cancer Cell Migration by the PI3K/Akt Signaling Pathway. Reprod Sci. 2016; 23(11):1600-1608. DOI: 10.1177/1933719116648214. View